LivaNova PLC (LIVN)

NASDAQ: LIVN · Real-Time Price · USD

79.50

-1.13 (-1.40%)

At close: Sep 15, 2026, 4:00 PM EDT

79.47

-0.03 (-0.04%)

After-hours: Sep 15, 2026, 7:30 PM EDT

LivaNova Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,472	1,388	1,253	1,154	1,022	1,035
Revenue Growth	12.39%	10.74%	8.66%	12.89%	-1.31%	10.82%
Gross Profit	996.85	944.07	854.78	768.42	707.23	705.99
Operating Income	207.55	211.39	165.39	69.55	81.56	48.9
Net Income	188.55	-242.47	63.23	17.55	-86.25	-135.82
Earnings Per Share	3.40	-4.45	1.16	0.32	-1.61	-2.68
EPS Growth	-	-	262.50%	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cardiopulmonary	840.02	785.39	683.51	604.11	514.2	482.98
Neuromodulation	620.98	592.81	554.22	519.71	476.99	456.17
Other	10.51	9.86	15.7	29.72	30.61	40.76
Total	1,472	1,388	1,253	1,154	1,022	1,035

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	516.62	635.55	428.86	266.5	215.51	207.99
Total Debt	351.95	433.77	676.77	640.4	580.43	286.7
Net Cash (Debt)	164.67	201.78	-247.92	-373.9	-364.92	-78.71
Net Cash Growth	48.54%	-	-	-	-	-
Net Cash Per Share	2.97	3.70	-4.54	-6.90	-6.82	-1.55

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	249.26	254.34	183.04	74.91	69.92	102.54
Capital Expenditures	-100.95	-81.05	-47.11	-34.98	-26.52	-25.48
Free Cash Flow	148.31	173.29	135.93	39.93	43.4	77.07
Free Cash Flow Growth	-8.51%	27.48%	240.40%	-8.00%	-43.68%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	67.74%	68.01%	68.19%	66.61%	69.21%	68.19%
Operating Margin	14.10%	15.23%	13.20%	6.03%	7.98%	4.72%
Pretax Margin	7.24%	-15.91%	7.04%	-7.05%	-7.36%	-12.04%
Profit Margin	12.81%	-17.47%	5.04%	1.52%	-8.44%	-13.12%
FCF Margin	10.08%	12.48%	10.85%	3.46%	4.25%	7.44%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	23.36	-	39.77	158.85	-	-
Forward PE	17.79	15.62	13.28	17.44	22.58	37.01
P/FCF Ratio	29.52	19.39	18.50	69.80	68.49	60.38
PS Ratio	2.98	2.42	2.01	2.42	2.91	4.50